ZA200607913B - Isoquinoline Derivatives and methods of use thereof - Google Patents

Isoquinoline Derivatives and methods of use thereof

Info

Publication number: ZA200607913B
Authority: ZA; South Africa
Prior art keywords: methods; isoquinoline derivatives; isoquinoline; derivatives
Prior art date: 2004-02-26

Application number

ZA200607913A

Other languages

English (en)

Inventor

Jagtap Prakash

Duzer John H Van

Andrew L Salzman

Williams William

Baloglu Erkan

Szabo Csaba

Roy Aloka

Nivorozhkin Alexander

Original Assignee

Inotek Pharmaceuticals Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-26

Filing date

2006-09-21

Publication date

2008-02-27

2006-09-21 Application filed by Inotek Pharmaceuticals Corp filed Critical Inotek Pharmaceuticals Corp

2008-02-27 Publication of ZA200607913B publication Critical patent/ZA200607913B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Oncology (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Obesity (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Endocrinology (AREA)

ZA200607913A 2004-02-26 2006-09-21 Isoquinoline Derivatives and methods of use thereof ZA200607913B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US54789904P	2004-02-26	2004-02-26

Publications (1)

Publication Number	Publication Date
ZA200607913B true ZA200607913B (en)	2008-02-27

Family

ID=34910959

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200607913A ZA200607913B (en)	2004-02-26	2006-09-21	Isoquinoline Derivatives and methods of use thereof

Country Status (14)

Country	Link
US (1)	US20050228007A1 (xx)
EP (2)	EP2033645A1 (xx)
JP (1)	JP2007527872A (xx)
KR (1)	KR20060125909A (xx)
CN (1)	CN1964716A (xx)
AU (1)	AU2005216978A1 (xx)
BR (1)	BRPI0508233A (xx)
CA (1)	CA2557547A1 (xx)
EA (1)	EA200601558A1 (xx)
IL (1)	IL177650A0 (xx)
MX (1)	MXPA06009701A (xx)
NO (1)	NO20064328L (xx)
WO (1)	WO2005082368A1 (xx)
ZA (1)	ZA200607913B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030096833A1 (en) *	2001-08-31	2003-05-22	Jagtap Prakash G.	Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof
US6956035B2 (en) *	2001-08-31	2005-10-18	Inotek Pharmaceuticals Corporation	Isoquinoline derivatives and methods of use thereof
EP1603567A4 (en) *	2003-02-28	2006-10-18	Inotek Pharmaceuticals Corp	TETRACYCLIC BENZAMIDE DERIVATIVES AND METHOD OF USE THEREOF
CN101014343A (zh) *	2004-02-26	2007-08-08	伊诺泰克制药公司	四环内酰胺衍生物及其应用
WO2006009718A2 (en) *	2004-06-16	2006-01-26	Inotek Pharmaceuticals Corporation	Methods for treating or preventing erectile dysfunction or urinary incontinence
US20060287311A1 (en) *	2005-02-25	2006-12-21	Inotek Pharmaceuticals Corporation	Tetracyclic Sulfonamide Compounds and methods of use thereof
AU2006219022A1 (en) *	2005-02-25	2006-09-08	Inotek Pharmaceuticals Corporation	Isoqunoline Compounds and methods of use thereof
CA2598647A1 (en) *	2005-02-25	2006-09-08	Inotek Pharmaceuticals Corporation	Tetracyclic amino and carboxamido compounds and methods of use thereof
CN101316592A (zh) *	2005-08-24	2008-12-03	伊诺泰克制药公司	茚并异喹啉酮类似物及其用法
AU2007266840B2 (en)	2006-05-31	2012-09-20	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa	Pyrrolo[1,2-A]pyrazin-1(2H)-one and pyrrolo[1,2-D][1,2,4]triazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose)polymerase(PARP)
MX2009007200A (es)	2007-01-10	2009-07-15	Angeletti P Ist Richerche Bio	Indazoles sustituidos con amida como inhibidores de poli(adp-ribosa)polimerasa (parp).
KR20090115879A (ko) *	2007-02-28	2009-11-09	이노텍 파마슈티컬스 코포레이션	인데노이소퀴놀리논 유사체와 이의 이용 방법
GB0716532D0 (en)	2007-08-24	2007-10-03	Angeletti P Ist Richerche Bio	Therapeutic compounds
ES2524787T3 (es)	2007-11-15	2014-12-12	Msd Italia S.R.L.	Derivados de piridazinona como inhibidores de PARP
GB0804755D0 (en)	2008-03-14	2008-04-16	Angeletti P Ist Richerche Bio	Therapeutic compounds
AU2009322342A1 (en)	2008-12-05	2011-06-30	Merck Sharp & Dohme Corp.	Morpholinone compounds as factor IXa inhibitors
KR20150009599A (ko) *	2012-06-20	2015-01-26	에프. 호프만-라 로슈 아게	탄키라아제의 피라노피리돈 억제제
KR102237639B1 (ko)	2012-10-11	2021-04-07	다이이찌 산쿄 가부시키가이샤	항체-약물 콘주게이트
ES2782248T3 (es)	2012-10-19	2020-09-11	Daiichi Sankyo Co Ltd	Conjugado de anticuerpo y fármaco producido por la unión a través de un enlazador que tiene estructura hidrófila
US11173213B2 (en)	2015-06-29	2021-11-16	Daiichi Sankyo Company, Limited	Method for selectively manufacturing antibody-drug conjugate
CN110049779A (zh)	2016-12-12	2019-07-23	第一三共株式会社	抗体-药物缀合物和免疫检查点抑制剂的组合
EP3572428A4 (en)	2017-01-17	2020-12-30	Daiichi Sankyo Company, Limited	ANTI-BODY ANTI-GPR20 AND ANTI-BODY-DRUG CONJUGATE ANTI-GPR20
TW202530271A (zh)	2017-05-15	2025-08-01	日商第一三共股份有限公司	抗體－藥物結合物及其用途
PE20251254A1 (es)	2017-05-24	2025-05-06	Novartis Ag	Proteinas de anticuerpo injertadas con citocina y metodos de uso en el tratamiento del cancer
KR20250084239A (ko)	2017-08-31	2025-06-10	다이이찌 산쿄 가부시키가이샤	항체-약물 콘주게이트의 개량 제조 방법
CA3074208C (en)	2017-08-31	2023-10-03	Daiichi Sankyo Company, Limited	Novel method for producing antibody-drug conjugate
US12479926B2 (en)	2018-05-18	2025-11-25	Daiichi Sankyo Co., Ltd.	Anti-MUC1 antibody-drug conjugate
US20190365735A1 (en) *	2018-05-31	2019-12-05	Campbell Frederick Mcauley	Compositions and methods for treating varicose veins
WO2020022475A1 (ja)	2018-07-27	2020-01-30	第一三共株式会社	抗体－薬物コンジュゲートの薬物部位を認識する蛋白質
US12220604B2 (en)	2018-07-31	2025-02-11	Daiichi Sankyo Company, Limited	Treatment of metastatic brain tumor by administration of an antibody-drug conjugate
CN111777613A (zh) *	2019-04-03	2020-10-16	中国药科大学	嘧啶二酮并吲哚和吡啶酮并吲哚类化合物的制备及用途
CN113480520B (zh) *	2021-08-16	2022-05-13	吉林大学	一种异喹啉-1,3（2h,4h）-二酮衍生物及其应用
CN118221674B (zh) *	2024-05-27	2025-01-28	南京市鸿舜医药科技有限公司	一种吡咯并[3,2-b]吡啶类Top/HDAC双靶点抑制剂、制法及其药物组合物和应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3710795A (en)	1970-09-29	1973-01-16	Alza Corp	Drug-delivery device with stretched, rate-controlling membrane
IT1054655B (it) *	1975-08-27	1981-11-30	Lepetit Spa	Derivati condensati del l isochinolina
US4263304A (en) *	1978-06-05	1981-04-21	Sumitomo Chemical Company, Limited	7 H-indolo[2,3-c]isoquinolines
US5177075A (en) *	1988-08-19	1993-01-05	Warner-Lambert Company	Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
GB8828806D0 (en) *	1988-12-09	1989-01-18	Beecham Group Plc	Novel compounds
US5028079A (en) *	1989-10-17	1991-07-02	J. M. Huber Corporation	Non-crushing wellhead
US5260316A (en) *	1991-07-30	1993-11-09	Ciba-Geigy Corporation	Isoquinolyl substituted hydroxylamine derivatives
US5597831A (en) *	1991-08-29	1997-01-28	Vufb A.S	6-[X-(2-hydroxyethyl) aminoalkyl]-5,11-dioxo-5,6-dihydro-11-H-indeno[1,2-c]isoquinolines and their use as antineoplastic agents
CZ281473B6 (cs)	1991-08-29	1996-10-16	Vúfb, A.S.	Deriváty 6-/X-(2-hydroxyethyl)aminoalkyl/-5,11 -dioxo-5,6-dihydro-11H-indeno/1,2-c/-isochinolinu a způsob jejich výroby
AU678982B2 (en) *	1992-08-14	1997-06-19	Commonwealth Scientific And Industrial Research Organisation	Insect viruses and their uses in protecting plants
US5262564A (en)	1992-10-30	1993-11-16	Octamer, Inc.	Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
TW440562B (en) *	1994-05-20	2001-06-16	Taiho Pharmaceutical Co Ltd	Condensed-indan derivative and pharmaceutically acceptable salts thereof
US6250301B1 (en)	1997-08-28	2001-06-26	Hortal Harm B.V.	Vaporizer for inhalation and method for extraction of active ingredients from a crude natural product or other matrix
US20020028813A1 (en)	1997-09-03	2002-03-07	Paul F. Jackson	Thioalkyl compounds, methods, and compositions for inhibiting parp activity
US6197785B1 (en)	1997-09-03	2001-03-06	Guilford Pharmaceuticals Inc.	Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6346536B1 (en) *	1997-09-03	2002-02-12	Guilford Pharmaceuticals Inc.	Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6514983B1 (en)	1997-09-03	2003-02-04	Guilford Pharmaceuticals Inc.	Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6635642B1 (en)	1997-09-03	2003-10-21	Guilford Pharmaceuticals Inc.	PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
AU9298198A (en)	1997-09-03	1999-03-22	Guilford Pharmaceuticals Inc.	Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
WO1999059975A1 (en)	1998-05-15	1999-11-25	Guilford Pharmaceuticals Inc.	Fused tricyclic compounds which inhibit parp activity
EP1077944A1 (en)	1998-05-15	2001-02-28	Guilford Pharmaceuticals Inc.	Carboxamide compounds, compositions, and methods for inhibiting parp activity
CN1217698C (zh) *	1998-08-24	2005-09-07	马克西姆药品公司	应用h2受体激动剂和其它t细胞活化剂激活和保护t细胞(cd4+和cd8+)
DE69940523D1 (de)	1998-10-14	2009-04-16	Purdue Research Foundation	Neue indenoisoquinoline als antineoplastische mittel
US6387902B1 (en)	1998-12-31	2002-05-14	Guilford Pharmaceuticals, Inc.	Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6201020B1 (en) *	1998-12-31	2001-03-13	Guilford Pharmaceuticals, Inc.	Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
AU781711B2 (en)	1999-01-11	2005-06-09	Agouron Pharmaceuticals, Inc.	Tricyclic inhibitors of poly(ADP-ribose) polymerases
US6346535B1 (en) *	1999-01-29	2002-02-12	American Cyanamid Company	Fungicidal mixtures
CA2377247A1 (en) *	1999-07-16	2001-01-25	Maxim Pharmaceuticals, Inc.	Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor
US6531464B1 (en) *	1999-12-07	2003-03-11	Inotek Pharmaceutical Corporation	Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives
US6277990B1 (en) *	1999-12-07	2001-08-21	Inotek Corporation	Substituted phenanthridinones and methods of use thereof
US6476048B1 (en) *	1999-12-07	2002-11-05	Inotek Pharamaceuticals Corporation	Substituted phenanthridinones and methods of use thereof
US6534651B2 (en) *	2000-04-06	2003-03-18	Inotek Pharmaceuticals Corp.	7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
AUPR201600A0 (en) *	2000-12-11	2001-01-11	Fujisawa Pharmaceutical Co., Ltd.	Quinazolinone derivative
US6956035B2 (en) *	2001-08-31	2005-10-18	Inotek Pharmaceuticals Corporation	Isoquinoline derivatives and methods of use thereof
US20030096833A1 (en) *	2001-08-31	2003-05-22	Jagtap Prakash G.	Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof
EP1603567A4 (en) *	2003-02-28	2006-10-18	Inotek Pharmaceuticals Corp	TETRACYCLIC BENZAMIDE DERIVATIVES AND METHOD OF USE THEREOF
CN101014343A (zh) *	2004-02-26	2007-08-08	伊诺泰克制药公司	四环内酰胺衍生物及其应用
WO2006009718A2 (en) *	2004-06-16	2006-01-26	Inotek Pharmaceuticals Corporation	Methods for treating or preventing erectile dysfunction or urinary incontinence
WO2006039545A2 (en) *	2004-09-30	2006-04-13	Maxim Pharmaceuticals, Inc.	Use of parp-1 inhibitors for protecting tumorcidal lymphocytes from apoptosis
US20060287311A1 (en) *	2005-02-25	2006-12-21	Inotek Pharmaceuticals Corporation	Tetracyclic Sulfonamide Compounds and methods of use thereof
CA2598647A1 (en) *	2005-02-25	2006-09-08	Inotek Pharmaceuticals Corporation	Tetracyclic amino and carboxamido compounds and methods of use thereof
AU2006219022A1 (en) *	2005-02-25	2006-09-08	Inotek Pharmaceuticals Corporation	Isoqunoline Compounds and methods of use thereof
CN101316592A (zh) *	2005-08-24	2008-12-03	伊诺泰克制药公司	茚并异喹啉酮类似物及其用法

2005
- 2005-02-25 MX MXPA06009701A patent/MXPA06009701A/es not_active Application Discontinuation
- 2005-02-25 CA CA002557547A patent/CA2557547A1/en not_active Abandoned
- 2005-02-25 CN CNA2005800131929A patent/CN1964716A/zh active Pending
- 2005-02-25 EP EP08015611A patent/EP2033645A1/en not_active Withdrawn
- 2005-02-25 AU AU2005216978A patent/AU2005216978A1/en not_active Abandoned
- 2005-02-25 US US11/066,824 patent/US20050228007A1/en not_active Abandoned
- 2005-02-25 JP JP2007501043A patent/JP2007527872A/ja not_active Withdrawn
- 2005-02-25 EA EA200601558A patent/EA200601558A1/ru unknown
- 2005-02-25 KR KR1020067019577A patent/KR20060125909A/ko not_active Withdrawn
- 2005-02-25 EP EP05723909A patent/EP1722797A4/en not_active Withdrawn
- 2005-02-25 WO PCT/US2005/006243 patent/WO2005082368A1/en not_active Ceased
- 2005-02-25 BR BRPI0508233-1A patent/BRPI0508233A/pt not_active IP Right Cessation
2006
- 2006-08-22 IL IL177650A patent/IL177650A0/en unknown
- 2006-09-21 ZA ZA200607913A patent/ZA200607913B/xx unknown
- 2006-09-25 NO NO20064328A patent/NO20064328L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20060125909A (ko)	2006-12-06
NO20064328L (no)	2006-10-26
WO2005082368A1 (en)	2005-09-09
US20050228007A1 (en)	2005-10-13
EP1722797A1 (en)	2006-11-22
EP2033645A1 (en)	2009-03-11
IL177650A0 (en)	2006-12-31
EP1722797A4 (en)	2008-03-19
MXPA06009701A (es)	2007-03-26
CA2557547A1 (en)	2005-09-09
BRPI0508233A (pt)	2007-07-17
JP2007527872A (ja)	2007-10-04
AU2005216978A1 (en)	2005-09-09
EA200601558A1 (ru)	2007-08-31
CN1964716A (zh)	2007-05-16

Publication	Publication Date	Title
IL177650A0 (en)	2006-12-31	Isoquinoline derivatives and methods of use thereof
PL378294A1 (pl)	2006-03-20	Pochodne izochinolinowe i sposoby ich stosowania
IL182734A0 (en)	2007-07-24	4-aminotetracyclines and methods of use thereof
EP1843768A4 (en)	2009-10-21	SUBSTITUTED MORPHINANES AND METHODS OF USE
IL176958A0 (en)	2006-12-10	Compounds and methods of use
IL181524A0 (en)	2007-07-04	Heterocyclic compounds and methods of use
ZA200600387B (en)	2009-06-24	Hydrolytically-resistant bornon-containing therapeutics and methods of use
PL378331A1 (pl)	2006-03-20	Tetracykliczne pochodne benzamidowe i sposoby ich stosowania
IL198397A0 (en)	2010-02-17	Anilinopiperazine derivatives and methods of use thereof
ZA200707083B (en)	2008-12-31	Isoquinoline compounds and methods of use thereof
IL172986A0 (en)	2006-06-11	Hairpin -labeled probes and methods of use
IL180978A0 (en)	2007-07-04	Isoindoline compounds and methods of their use
EP1817308A4 (en)	2007-12-26	CYCLOPAMINE ANALOGS AND METHODS OF USE THEREOF
IL177012A0 (en)	2008-04-13	Quinoline derivatives and use thereof as mycobacterial inhibitors
EP1827391A4 (en)	2010-03-17	DOSAGE FORMS AND METHODS OF USE THEREOF
ZA200710173B (en)	2009-09-30	Tygecycline and methods of preparing 9-nitrominocycline
ZA200804688B (en)	2009-04-29	Purine derivatives and methods of use thereof
GB0708824D0 (en)	2007-06-20	Improved underreamer and method of use
EP1817277A4 (en)	2010-03-10	PHENYL DERIVATIVES AND METHOD OF USE
TWI339662B (en)	2011-04-01	Arylvinylazacycloalkane compounds and methods of preparation and use thereof
IL176772A0 (en)	2006-10-31	Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
EP1812451A4 (en)	2009-10-21	COMPOUNDS AND METHODS OF USE THEREOF
ZA200606070B (en)	2007-12-27	Substituted quinolines and their use as mycrobacterial inhibitors
IL186277A0 (en)	2008-01-20	Dnt-maleate and methods of preparation thereof
SG115828A1 (en)	2005-10-28	Fluid-ejection device and methods of forming same